Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis A Population-Based Study

被引:317
|
作者
Perez, Evans R. Fernandez [1 ]
Daniels, Craig E. [2 ]
Schroeder, Darrell R. [3 ]
St Sauver, Jennifer [4 ]
Hartman, Thomas E. [5 ]
Bartholmai, Brain J. [5 ]
Yi, Eunhee S. [6 ]
Ryu, Jay H. [2 ]
机构
[1] Natl Jewish Hlth, Autoimmune Lung Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Denver, CO 80206 USA
[2] Mayo Clin, Coll Med, Div Pulm & Crit Care Med, Dept Internal Med, Rochester, MN USA
[3] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Biostat, Rochester, MN USA
[4] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA
[5] Mayo Clin, Coll Med, Dept Radiol, Div Thorac Radiol, Rochester, MN USA
[6] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Div Anat Pathol, Rochester, MN USA
关键词
INTERSTITIAL LUNG-DISEASES; EPIDEMIOLOGY; REGISTRATION; SURVIVAL;
D O I
10.1378/chest.09-1002
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Limited data exist regarding the population-based epidemiology of idiopathic pulmonary fibrosis (IPF). The objective of the study was to describe the trends in the incidence, prevalence, and clinical course of IPF in the community. Methods: We conducted a population-based study of adult patients with IPF in Olmsted County, Minnesota, from 1997 to 2005. Two methods were used to identify IPF cases, as defined by the 2002 American Thoracic Society/European Respiratory Society consensus statement: (1) usual interstitial pneumonia (UIP) on a surgical lung biopsy specimen or a definite UIP pattern on a high-resolution CT image (narrow criteria) and (2) UIP on a surgical lung biopsy specimen or a definite or possible UIP pattern on CT image (broad criteria). Results: Of 596 patients screened for the possibility of pulmonary disease or pulmonary fibrosis over 9 years of follow-up, 47 cases had IPR Of these, 24 met the narrow criteria. The age- and sex-adjusted incidence was 8.8/100,000 and 17.4/100,000 person-years, for narrow and broad criteria, respectively. The age-adjusted incidence was higher in men than in women, and among patients aged 70-79 years. During the study, period, the incidence of IPF decreased (P<.001). On December 31, 2005, the age- and sex-adjusted prevalence was 27.9/100,000 and 63,1100,000 persons by narrow and broad criteria, respectively. Thirty-seven patients experienced a total of 53 respiratory exacerbations (26 IPF related, 27 non-IPF related), and 34 (72%) patients died. The primary cause of death was IPF related in 16 (47%) patients. Median survival for narrow-criteria and broad-criteria incidence cases was 3.5 and 4.4 years, respectively. Conclusions: The incidence of IPF in Olmsted County decreased over the study period. Nonprimary IPF respiratory exacerbations are as frequent as primary IPF respiratory exacerbations and an important cause of death. CHEST 2010; 137(1):129-137
引用
收藏
页码:129 / 137
页数:9
相关论文
共 50 条
  • [31] Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis A Population-Based Cohort Study
    Tran, Tanja
    Assayag, Deborah
    Ernst, Pierre
    Suissa, Samy
    CHEST, 2021, 159 (02) : 673 - 682
  • [32] IDIOPATHIC PULMONARY FIBROSIS (IPF) INCIDENCE AND PREVALENCE IN ITALY
    Agabiti, Nera
    Porretta, Maria Assunta
    Bauleo, Lisa
    Coppola, Angelo
    Sergiacomi, Gianluigi
    Fusco, Armando
    Cavalli, Francesco
    Zappa, Maria Cristina
    Vignarola, Rossana
    Carlone, Stefano
    Facchini, Giampiero
    Mariotta, Salvatore
    Palange, Paolo
    Valente, Salvatore
    Pasciuto, Giovanna
    Pezzuto, Gabriella
    Orlandi, Augusto
    Fusco, Danilo
    Davoli, Marina
    Saltini, Cesare
    Puxeddu, Ermanno
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2014, 31 (03) : 191 - 197
  • [33] Prevalence And Clinical Characteristics Of Idiopathic Pulmonary Fibrosis
    Raimundo, K.
    Chang, E.
    Broder, M.
    Carrigan, G.
    Zazzali, J.
    Swigris, J. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea
    Lee, H-E.
    Myong, J-P.
    Kim, H-R.
    Rhee, C. K.
    Yoon, H-K.
    Koo, J-W.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (07) : 978 - 984
  • [35] Incidence of Idiopathic Ventricular Arrhythmias A Population-Based Study
    Sirichand, Surksha
    Killu, Ammar M.
    Padmanabhan, Deepak
    Hodge, David O.
    Chamberlain, Alanna M.
    Brady, Peter A.
    Kapa, Suraj
    Noseworthy, Peter A.
    Packer, Douglas L.
    Munger, Thomas M.
    Gersh, Bernard J.
    McLeod, Christopher J.
    Shen, Win-Kuang
    Cha, Yong-Mei
    Asirvatham, Samuel J.
    Friedman, Paul A.
    Mulpuru, Siva K.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (02):
  • [36] Population-based incidence and clinical characteristics of idiopathic intracranial hypertension
    Sundholm, A.
    Burkill, S.
    Sveinsson, O.
    Piehl, F.
    Bahmanyar, S.
    Remahl, A. I. M. Nilsson
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (05): : 427 - 433
  • [37] PULMONARY ALVEOLAR PROTEINOSIS IN KOREA: ANALYSIS OF PREVALENCE AND INCIDENCE BY A NATIONWIDE POPULATION-BASED STUDY
    Yoon, Hee-Young
    Kim, Ye-Jee
    Song, Jin Woo
    RESPIROLOGY, 2018, 23 : 36 - 36
  • [38] Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study
    Baqir, Misbah
    Vasirreddy, Amit
    Vu, Ann N.
    Moua, Teng
    Chamberlain, Alanna M.
    Frank, Ryan D.
    Ryu, Jay H.
    RESPIRATORY MEDICINE, 2021, 178
  • [39] Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based case-control study
    Baqir, Misbah
    Vu, Ann
    Moua, Teng
    Vasireddy, Amit
    Chamberlain, Alanna
    Frank, Ryan
    Ryu, Jay
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [40] PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS: PREVALENCE AND CLINICAL PROGRESS
    Castria, D.
    Refini, R. M.
    Bargagli, E.
    Mezzasalma, F.
    Pierli, C.
    Rottoli, P.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (03) : 681 - 689